In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1767-1769

  Hou, Zhi Bo ^a   Lu, Kai Jin ^b   Wu, Xiao Li ^c   Chen, Cong ^d   Huang, Xin En ^e   Yin, Hai Tao ^f  

^a NANJING CHEST HOSPITAL   (China)

^b People's Hospital of Jiangsu   (China)

^c WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^e JIANGSU CANCER HOSPITAL   (China)

^f XUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Antitumor; Berbamine; Lung cancer; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BENZYLISOQUINOLINE DERIVATIVE; BERBAMINE; CALCIUM CHANNEL BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; FEMALE; HUMAN; LUNG TUMOR; MALE; MORTALITY; MOUSE; NUDE MOUSE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BENZYLISOQUINOLINES; CALCIUM CHANNEL BLOCKERS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84896965587     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1767     Document Type: Article

References (12)

1. Gu Y, Chen T, Meng Z, et al (2012). CaMKII gamma, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. Blood, 120, 4829-39.
2. Ji ZN, Ye WC, Liu GQ, et al (2002). Inhibition of telomerase activity and bcl-2 expression in berbamine-induced apoptosis in HL-60 cells. Planta Med, 68, 596-600.
3. Kim JL1, Cho KH, Park EC, et al (2014). A single measure of cancer burden combining incidence with mortality rates for worldwide application. Asian Pac J Cancer Prev, 15, 433-9.
4. Kittakoop P, Mahidol C, Ruchirawat S (2014). Alkaloids as important scaffolds in therapeutic drugs for the treatments of cancer, tuberculosis, and smoking cessation. Curr Top Med Chem, 14, 239-52.
5. Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection (Yadanzi®) combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4.
6. Meng Z, Li T, Ma X, et al (2013). Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca (2) (+)/calmodulin-dependent protein kinase II. Mol Cancer Ther, 12, 2067-77.
7. Pikor LA, Ramnarine VR, Lam S, et al (2013). Genetic alterations defining NSCLC subtypes and their therapeutic implications. Lung Cancer, 82, 179-89.
8. Qin R, Shen H, Cao Y, et al (2013). Tetrandrine induces mitochondria-mediated apoptosis in human gastric cancer BGC-823 cells. PloS One, 8, e76486.
9. Song S, Zhu S, Zhang Z, et al (2013). A study on the inhibitory effect of matrine on gastric cancer SGC-7901 cells. Afr J Tradit Complement Altern Med, 10, 435-8.
10. Wang S, Liu Q, Zhang Y, et al (2009). Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Mol Cancer, 8, 81.
11. Wang X, Song ZF, Xie RM, et al (2013). Analysis of death causes of in-patients with malignant tumors in Sichuan Cancer Hospital of China from 2002 to 2012. Asian Pac J Cancer Prev, 14, 4399-402.
12. Yan HA, Shen K, Huang XE (2013). Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4801-4.